PARP Inhibitors Quick Guide — Understanding The Different Drugs & Who May Benefit

Medically Reviewed

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles
6) Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated February 28th, 2022

PARP Inhibitors Quick Guide — Understanding The Different Drugs & Who May Benefit

NOW
PLAYING
Friends Rally About Beloved Comedian Lyndsey Frank As She Bravely Battles Breast Cancer
NOW
PLAYING
Netflix 'Home Edit' Star Clea Shearer, 40, Announces New Fund For Breast Cancer Research Even As She's Fighting Breast Cancer Herself
NOW
PLAYING
A Miracle Baby! Young Couple, 29 and 31, Who Both Had Cancer As Teens And Thought Chemo Made Them Sterile, Joyfully Become Parents At Last
NOW
PLAYING
Clinical Trials and What Statistics Really Mean
NOW
PLAYING
New Drug Combo Shows Promise in Treating Relapsed Multiple Myeloma
NOW
PLAYING
Study Indicates The Drug Panitumumab Works Best For Patients With One Type Of Metastatic Colorectal Cancer

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.